The new single-use commercial facility will be among India’s largest, featuring advanced technologies to produce high-quality biologics and specialty pharmaceuticals
Shonan iPark was chosen for its globally connected life-science ecosystem, which unites pharmaceutical firms, next-generation medicine developers, AI and digital health innovators, venture capital, and academia
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
Tablets will be manufactured at Granules' US-based facility located in Chantilly, Virginia
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
USFDA determines Sun Pharma's Baska facility inspection classification as OAI
The approval comes with 180 days of Competitive Generic Therapy (CGT) exclusivity,
Company acquires People Tree Hospital Yeshwanthpur for Rs. 430 crore
The new facility is expected to generate 500-600 new jobs in the region
Subscribe To Our Newsletter & Stay Updated
